Vertex reports results from Phase IIb AMPLIFIED trial for AMKD
Vertex Pharmaceuticals has reported positive data from its Phase IIb AMPLIFIED trial evaluating inaxaplin in individuals with AMKD.
The post Vertex reports results from Phase IIb AMPLIFIED trial for AMKD appeared first on Clinical Trials Arena .